4893 items matching your search terms.

Current status of the ANZUP germ cell trials

Grimison, P

Accelerated BEP for advanced germ cell tumours: an Australian multicentre phase I/II trial

Grimison, P Stockler, M Thomson, D Chatfield, M Friedlander, M Gebski, V Boland, A Gurney, H Rosenthal, M Toner, G

Accelerated BEP for advanced germ-cell tumours: an Australian multicentre phase I–II triaL

Grimison, P Stockler, M Thomson, D Chatfield, M Friedlander, M Gebski, V Boland, A Gurney, H Rosenthal, M Toner, G

Accelerated BEP for advanced germ cell tumors: an Australian multicenter phase I/II trial

Grimison, PS Thomson, DB Stockler, MR Chatfield, MD Friedlander, M Gebski, V Boland, AL Houghton, BB Gurney, H Rosenthal, M Singhal, N Kichenadasse, G Wong, SS Lewis, CR Vasey, PA Toner, GC; Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Accelerated BEP for advanced germ cell tumours: an ongoing multi-centre phase I/II trial

Grimison, PS Thomson, DB Stockler, M Friedlander, M Gebski, V Boland, AL Chatfield, M Rosenthal, M Gurney, H Toner, GC Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Management of advanced germ cell tumors: IGCCC intermediate- and poor-risk patients

Grimison, PS Toner, GC

Rates and risk predictors of stroke and its subtypes among people with diabetes mellitus

Hankey, GJ Ting, R Veillard, AS Anderson, NE Wosik, M Keech, AC Sullivan, D Romo, M.

Fenofibrate and carotid intima-media thickness in adults with type 2 diabetes mellitus: a FIELD substudy

Harmer, J Veillard, AS Skilton, M Keech, A Celermajer, D

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes

Hayes, AJ Clarke, PM Voysey, M Keech, A
MEDICAL DECISION MAKING, 2011     DOI:10.1177/0272989X11409049

Simulation of quality-adjusted survival in chronic diseases: An application in type 2 diabetes

Hayes, A. J. Clarke, P. M. Voysey, M. Keech, A.
MEDICAL DECISION MAKING, 2011     DOI:10.1177/0272989X11409049

Sequential BCG and mitomycin intravesical therapy versus BCG alone for high-risk non-muscle invasive bladder cancer: pilot study and proposal for a 2-stage randomized phase III trial

Hayne, D Stockler, M Ives, A Houghton, B Braganza, P Chalasani, V Patel, M ANZUP Bladder Cancer Subcommittee,

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study

Heart Protection Study Collaborative Group,
LANCET, 2011     DOI:Doi: 10.1016/s0140-6736(10)62174-5

A study of methylated glutathione s-transferase 1 as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer

Horvath, L Mahon, KL Qu, W Devaney, J Chatfield, MD Paul, C Wykes, R Boyer, MJ Stockler, MR Marx, GM Sutherland, RL Clark, SJ

The effect of pulmonary function testing on bleomycin dosing in germ-cell tumors

Houghton, B Grimison, PS Toner, GC Chatfield, M Thomson, DB Friedlander, M Gebski, V Boland, A Rosenthal, M Gurney, H Stockler, M

Intravesical chemotherapy plus BCG in non-muscle invasive bladder cancer. A systematic review with meta-analysis

Houghton, B. Hayne, D. Brown, C. Chalasani, V. Patel, M. Davis, I. Stockler, M.